The impact of teriparatide adherence and persistence on fracture outcomes

Osteoporosis International

Volumn 23, Issue 3, 2012, Pages 1103-1113

  Yu, S ^a   Burge, R T ^b   Foster, S A ^b   Gelwicks, S ^b   Meadows, E S ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Adherence; Fractures; Osteoporosis; Outcomes; Persistence; Teriparatide

Indexed keywords

PARATHYROID HORMONE[1-34];

AGED; ARTICLE; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK; VERTEBRA FRACTURE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; FEMALE; FRACTURES, BONE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; PROGNOSIS; RISK ASSESSMENT; TERIPARATIDE; UNITED STATES; YOUNG ADULT;

EID: 84857442884     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1843-3     Document Type: Article

References (25)

1. US Department of Health and Human Services, Office of the Surgeon General (2004) Bone health and osteoporosis: a report of the Surgeon General. Office of the Surgeon General, Rockville
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 2001 Osteoporosis Prevention, Diagnosis, and Therapy JAMA 285 785 795 10.1001/jama.285.6.785
3. R Burge B Dawson-Hughes DH Solomon, et al. 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465 475 17144789 10.1359/jbmr.061113 (Pubitemid 46797130)
4. Eli Lilly and Company (2010) Forteo package insert. Available at http://pi.lilly.com/us/forteo-pi.pdf. Accessed 25 Mar 2010
5. E Seeman J Compston J Adachi, et al. 2007 Non-compliance: the Achilles' heel of anti-fracture efficacy Osteoporos Int 18 711 719 17245547 10.1007/s00198-006-0294-8 1:STN:280:DC%2BD2s3mt1Sksg%3D%3D (Pubitemid 46684777)
6. E Siris P Selby KG Saag F Borgström R Herings SL Silverman 2009 Impact of osteoporosis treatment adherence on fracture rates in North America and Europe Am J Med 122 S3 S13 19187810 10.1016/j.amjmed.2008.12.002
7. ES Siris ST Harris CJ Rosen CE Barr JN Arvesen TA Abbott, et al. 2006 Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013 1022 16901023 10.4065/81.8.1013 (Pubitemid 44175011)
8. FJ Penning-van Beest JA Erkens M Olson RM Herings 2008 Loss of treatment benefit due to low compliance with bisphosphonate therapy Osteoporos Int 19 511 517 17874028 10.1007/s00198-007-0466-1 1:STN:280:DC%2BD1c7nvFWqtw%3D%3D
9. D Weycker D Macarios J Edelsberg G Oster 2007 Compliance with osteoporosis drug therapy and risk of fracture Osteoporos Int 18 271 277 17021945 10.1007/s00198-006-0230-y 1:STN:280:DC%2BD2s%2FoslKktg%3D%3D (Pubitemid 46233172)
10. R Halpern L Becker S Usman Iqbal LE Kazis D Macarios E Badamgarav 2011 The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis J Manag Care Pharm 17 25 39 21204588
11. JJ Caro KJ Ishak KF Huybrechts G Raggio C Naujoks 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003 1008 15167989 10.1007/s00198-004-1652-z (Pubitemid 40064656)
12. AM Gallagher S Rietbrock M Olson TP van Staa 2008 Fracture outcomes related to persistence and compliance with oral bisphosphonates J Bone Miner Res 23 1569 1575 18505366 10.1359/jbmr.080510
13. R Lindsay P Miller G Pohl E Glass P Chen JH Krege 2009 Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis Osteoporos Int 20 943 948 18923884 10.1007/s00198-008- 0766-0 1:CAS:528:DC%2BD1MXls12kt7w%3D
14. Silverman, SL, Miller P, Sebba AI, Weitz M, Wan X, Taylor K, Ruff V (2010) The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results. [abstract]. Arthritis Rheum 62 Suppl 10:980. doi: 10.1002/art.28747
15. B Langdahl G Rajzbaum F Jacob, et al. 2009 Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS) Calcif Tissue Int 85 484 493 19823760 10.1007/s00223-009-9299-6 1:CAS:528:DC%2BD1MXhsFSrt7fN
16. SA Foster KA Foley ES Meadows, et al. 2008 Characteristics of patients initiating teriparatide for the treatment of osteoporosis Osteoporos Int 19 373 377 17710352 10.1007/s00198-007-0455-4 1:CAS:528:DC%2BD1cXhtlOqs70%3D (Pubitemid 351199179)
17. SA Foster KA Foley ES Meadows, et al. 2011 Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance Osteoporos Int 22 551 557 20798929 10.1007/s00198-010-1297-z 1:STN:280:DC%2BC3M7gslSqsA%3D%3D
18. RH Lee KW Lyles C Colon-Emerec 2010 A review of the effect of anticonvulsant medications on bone mineral density and fracture risk J Am Ger Soc 8 34 46 1:CAS:528:DC%2BC3cXosVWqur0%3D
19. SJ Petty TJ O'Brien JD Wark 2007 Anti-epileptic medication and bone health Osteoporos Int 18 129 142 17091219 10.1007/s00198-006-0185-z 1:STN:280:DC%2BD2s%2FitVWmuw%3D%3D (Pubitemid 46090218)
20. DM Black T Reiss MC Nevitt, et al. 1993 Design of the Fracture Intervention Trial Osteoporos Int 3 Suppl. 3 S29 S39 8298200 10.1007/BF01623005
21. SR Cummings J San Martin MR McClung, et al. 2009 Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 1 10 10.1056/NEJMoa0809493
22. MR McClung P Geusens PD Miller, et al. 2001 Effect of risedronate on the risk of hip fracture in elderly women N Engl J Med 344 333 340 11172164 10.1056/NEJM200102013440503 1:CAS:528:DC%2BD3MXht1Wlu7g%3D (Pubitemid 32107641)
23. S Ross E Samuels K Gairy, et al. 2011 A meta-analysis of osteoporotic fracture risk with medication nonadherence Value Health 14 4 571 581 21669382 10.1016/j.jval.2010.11.010
24. RM Neer CD Arnaud JR Zanchetta, et al. 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441 11346808 10.1056/NEJM200105103441904 1:CAS:528:DC%2BD3MXktVSgsbw%3D (Pubitemid 32402100)
25. A Fahrleitner-Pammer BL Langdahl F Marin F Jakob, et al. 2011 Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS) Osteoporos Int 22 2709 2719 21113576 10.1007/s00198-010-1498-5 1:STN:280:DC%2BC3MfitVOhuw%3D%3D